Back

Personalized Pulmonary Vein Isolation with Very High-Power Short-Duration Lesions guided by Left Atrial Wall Thickness: the QDOT-by-LAWT Randomized Trial

8 April 2024 (13:51 - 13:59)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Diego Penela

Medical Centre Teknon, Grupo Quironsalud, Barcelona (Spain)

9 More presentations in this session

Presentation thumbnail
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies
Doctor A. Verma (Montreal, CA)
Slides Video
Presentation thumbnail
The Safety and Effectiveness of Ultra-low Temperature Cryoablation of Monomorphic VT in Patients with Ischemic and Non-Ischemic Cardiomyopathies - discussion
Doctor U. Tedrow (Boston, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation
Professor V. Reddy (New York City, US)
Slides Video
Presentation thumbnail
First-in-Human Clinical Series of a Novel Conformable "Single-Shot" Pulsed Field Ablation Catheter for Pulmonary Vein Isolation - discussion
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences despite Durable Pulmonary Vein Isolation
Doctor B. Schmidt (Frankfurt, DE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science: ablation
Video

The Event

Event poster

EHRA 2024

8 April 2024 13:51 CET
You may be interested in
thumbnail
Congress Presentation
Personalized Pulmonary Vein Isolation with Very High-Power Short-Duration Lesions guided by Left Atrial Wall Thickness: the QDOT-by-LAWT Randomized Trial - discussion
thumbnail
Congress Session
Late-Breaking Science: ablation
thumbnail
Congress Presentation
The multicenter ablate-by-LAW study: personalized paroxysmal atrial fibrillation ablation according to the local left atrial wall thickness.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources